INS and metabolic dysfunction-associated steatotic liver disease: In the same year, a randomized controlled trial (n = 60 overweight NAFLD patients) [118] conducted for 8 weeks demonstrated a significant reduction in body weight, serum triglyceride level, VLDL, liver enzymes and a concurrent improvement in insulin sensitivity, oxidative stress and inflammation biomarkers in the DASH diet group vs. controls who received a calorie-restricted diet.